Transgenic Expression of PML/RARα Impairs Myelopoiesis

The translocation found in acute promyelocytic leukemia rearranges the promyelocytic leukemia gene (PML) on chromosome 15 with the retinoic acid receptor α (RARα ) on chromosome 17. This yields a fusion transcript, PML/RARα , a transcription factor with reported dominant negative functions in the ab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 1996-07, Vol.93 (15), p.7900-7904
Hauptverfasser: Early, Ellen, Malcolm A. S. Moore, Kakizuka, Akira, Nason-Burchenal, Kathryn, Martin, Patrick, Evans, Ronald M., Dmitrovsky, Ethan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The translocation found in acute promyelocytic leukemia rearranges the promyelocytic leukemia gene (PML) on chromosome 15 with the retinoic acid receptor α (RARα ) on chromosome 17. This yields a fusion transcript, PML/RARα , a transcription factor with reported dominant negative functions in the absence of hormone. Clinical remissions induced with all-trans retinoic acid (RA) treatment in acute promyelocytic leukemia are linked to PML/RARα expression in leukemic cells. To evaluate the PML/RARα role in myelopoiesis, transgenic mice expressing PML/RARα were engineered. A full-length PML/RARα cDNA driven by the CD11b promoter was expressed in transgenic mice. Expression was confirmed in the bone marrow with a reverse transcription PCR assay. Basal total white blood cell and granulocyte counts did not appreciably differ between PML/RARα transgenic and control mice. Cell sorter analysis of CD11b+ bone marrow cells revealed similar CD11b+ populations in transgenic and control mice. However, in vitro clonal growth assays performed on peripheral blood from transgenic versus control mice revealed a marked reduction of myeloid progenitors, especially in those responding to granulocyte/macrophage colony-stimulating factor. Granulocyte/macrophage colony-stimulating factor and kit ligand cotreatment did not overcome this inhibition. Impaired myelopoiesis in vivo was shown by stressing these mice with sublethal irradiation. Following irradiation, PML/RARα transgenic mice, as compared with controls, more rapidly depressed peripheral white blod cell and granulocyte counts. As expected, nearly all control mice (94.4%) survived irradiation, yet this irradiation was lethal to 45.8% of PML/RARα transgenic mice. Lethality was associated with more severe leukopenia in transgenic versus control mice. Retinoic acid treatment of irradiated PML/RARα mice enhanced granulocyte recovery. These data suggest that abnormal myelopoiesis due to PML/RARα expression is an early event in oncogenic transformation.
ISSN:0027-8424
DOI:10.1073/pnas.93.15.7900